Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats

Hepatology

Volumn 25, Issue 4, 1997, Pages 820-827

  Vogels, Blrgit A P M ^a   Maas, Martinus A W ^a   Daalhuisen, Joost ^a   Quack, Günter ^b   Chamuleau, Robert A F M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; INTRACRANIAL PRESSURE; LIVER ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROSCOPY; WATER CONTENT;

AMMONIA; ANIMALS; BODY WATER; BRAIN; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; GLUTAMIC ACID; HEPATIC ENCEPHALOPATHY; INTRACRANIAL PRESSURE; ISCHEMIA; LIVER; MALE; MEMANTINE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030990406     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250406     Document Type: Article

References (20)

1. Butterworth RF, Giguère JF, Michaud J, Lavoie J, Pomier Layrargues G. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987;6:1-12.
2. Williams AH, Kyu MH, Fenton JCB, Cavanagh JB. The glutamate and glutamine content of rat brain after portacaval anastomosis. J Neurochem 1972;19:1073-1077.
3. 1H-NMR spectroscopy and biochemical investigation. HEPATOLOGY 1990;12: 281-290.
4. Mans AM, de Joseph MR, Donald WD, Vina JR, Hawkins RA. Early establishment of cerebral dysfunction after portacaval shunting. Am J Physiol 1990;259:E104-E110.
5. Swain M, Butterworth RF, Blei AT. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. HEPATOLOGY 1992;15:449-453.
6. 1H NMR spectroscopy in patients with chronic encephalopathy: analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991;4:109-116.
7. Chamuleau RAFM, Bosman DK, Boveé WMMJ, Luyten PR, de Hollander JA. What the clinician can learn from NMR glutamine/glutamate assays. NMR Biomed 1991;4:103-108.
8. Blei AT, Olafsson S, Therrien G, Butterworth RF. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. HEPATOLOGY 1994;19:1437-1444.
9. Vogels BAPM, van Steynen B, Maas MAW, Jorning GGA, RAFM Chamuleau. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyper-ammonemia-induced encephalopathy. J Hepatol 1997;26:387-395.
10. Ware AJ, D'Agostino A, Combes B. Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology 1971;61:877-884.
11. Moroni F, Lombardi G, Moneti G, Cortesini C. The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 1983;40:850-854.
12. Bosman DK, Deutz NEP, Maas MAW, van Eijk HMH, Smit JJH, de Haan JG, Chamuleau RAFM. Amino acid release from cerebral cortex in experimental acute liver failure, studied by in vivo cerebral cortex microdialysis, J Neurochem 1992;59:591-599.
13. Swain MS, Bergeron M, Audet R, Blei AT, Butterworth RF. Monitoring of neurotransmitter amino acids by means of an indwelling cisterna magna catheter: a comparison of two rodent models of fulminant liver failure. HEPATOLOGY 1992;16:1028-1035.
14. de Knegt RJ, Schalm SW, vd Rijt CCD, Fekkes D, Dalm E, Hekking-Weyma I. Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis. J Hepatol 1994;20:19-26.
15. Van Sande M, Mardens Y, Adriaenssens K, Lowenthal A. The free amino acids in human cerebrospinal fluid. J Neurochem 1970;17:125-135.
16. Vergara F, Plum F, Duffy TE. α-Ketoglutaramate: increased concentrations in the cerebrospinal fluid of patients with hepatic coma. Science 1974;183:81-83.
17. Watanabe A, Takei N, Higashi T. Glutamic acid and glutamine levels in serum and cerebrospinal fluid in hepatic encephalopathy. Biochem Med 1984;32:225-231.
18. Scatton B. The NMDA receptor complex. Fundam Clin Pharmacol 1993; 7:389-400.
19. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987; 7:369-379.
20. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor. Trends Neurosci 1987;10:299-302.